Aging rat brain: a model for analyzing interactions among CSF dynamics, ventriculomegaly and the β-amyloid retention of alzheimer's disease
© The Author(s) 2005
Published: 30 December 2005
Age-associated disruptions in brain barrier systems (including choroid plexus) lead to multiple problems for CSF turnover and brain interstitial fluid composition. Age is a great risk factor for Alzheimer's disease (AD). We have presented evidence that beta-amyloid (Aβ) retention in AD is linked to decreased CSF turnover and reduced Aβ transport out of human brain. It is also known that CSF formation is reduced in aged rats (Preston et al.).
Materials and methods
To extend this model, we sought evidence to confirm the postulated Aβ retention in the brain of old animals. Brown-Norway/Fischer (B-N/F) rats, at 3 mo (young adult) and 30 mo (advanced age), were used to characterize the presence of Aβ 1–42 fragments in various regions of CNS. Immunohistochemistry was used to assess the degree and localization of Aβ 1–42 both the cerebral cortex (CC) and lateral ventricle choroid plexus.
In the young adult B-N/F animals, there was negligible Aβ 1–42 staining in the CC. In contrast, there was substantial amyloid staining, primarily in neurons, in the 30-mo-old CC. At the blood-CSF barrier, the choroidal epithelium displayed some Aβ 1–42 staining even at 3 mo, suggesting reabsorptive clearance transport of this peptide fragment from the CSF. However, in the 30-mo rats, there was increased staining of the amyloid 1–42 in the plexus.
These findings point to a greater burden of Aβ in the CNS as the result of advanced aging. Thus, this accumulating Aβ in cortical and choroidal tissues is consistent with the independent observations of a slower flow of CSF in older animals. The parallel findings of Aβ retention and CSF slowing, in aged rats vs. human AD subjects, encourage further mechanistic studies in B-N/F animals to delineate functional relationships among Aβ transport, CSF formation/volume, and Aβ retention in hippocampal and cortical regions.
Supported by Lifespan and the Department of Neurosurgery at Rhode Island Hospital, the Rae Richter Alzheimer's Disease Research Fund at Stanford University, and by NIH NS RO1 27601 (CEJ).
This article is published under license to BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.